Related Experiment Video

Updated: Apr 26, 2026

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.8K

Merkel cell carcinoma: current status of targeted and future potential for immunotherapies

Bishr Aldabagh1, Jayne Joo, Siegrid S Yu

  • 1Department of Dermatology, University of California in San Francisco CA USA.

Seminars in Cutaneous Medicine and Surgery
|August 3, 2014
PubMed

Insights

Merkel cell carcinoma, an aggressive neuroendocrine tumor, often recurs and metastasizes. This review discusses new molecular targets and immunotherapies beyond traditional surgery and radiation.

Area of Science:

  • Oncology
  • Virology
  • Immunology

Background:

  • Merkel cell carcinoma (MCC) is an aggressive neuroendocrine skin cancer.
  • MCC has a high rate of recurrence, metastasis, and mortality.
  • MCC is associated with polyomavirus infection and immune suppression.

Purpose of the Study:

  • To review current understanding of Merkel cell carcinoma.
  • To explore molecular pathways in MCC carcinogenesis and infection.
  • To discuss emerging molecular targets and immunotherapies for MCC treatment.

Main Methods:

  • Literature review of Merkel cell carcinoma research.
  • Analysis of molecular pathways in MCC.
  • Synthesis of information on novel therapeutic strategies.

Main Results:

  • MCC's aggressive nature and high mortality are confirmed.
  • Polyomavirus and immune suppression are key factors in MCC development.
  • Understanding molecular pathways opens avenues for targeted therapies.

Conclusions:

  • Traditional treatments for MCC (surgery, radiation) have limitations.
  • Emerging molecular targets and immunotherapies offer new hope for MCC patients.
  • Further research into MCC's molecular mechanisms is crucial for advancing treatment.

More Related Videos

A 3D Organotypic Melanoma Spheroid Skin Model08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

18.1K
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology07:04

Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology

Published on: May 2, 2025

1.3K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K